JP2004525873A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004525873A5 JP2004525873A5 JP2002551496A JP2002551496A JP2004525873A5 JP 2004525873 A5 JP2004525873 A5 JP 2004525873A5 JP 2002551496 A JP2002551496 A JP 2002551496A JP 2002551496 A JP2002551496 A JP 2002551496A JP 2004525873 A5 JP2004525873 A5 JP 2004525873A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- mono
- alkoxy
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1ccc(-c2ccccc2C(N(*)*)=O)[s]1 Chemical compound Cc1ccc(-c2ccccc2C(N(*)*)=O)[s]1 0.000 description 66
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/026816 WO2002049993A2 (en) | 2000-09-29 | 2000-09-29 | High affinity small molecule c5a receptor modulators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011092825A Division JP2011219476A (ja) | 2011-04-19 | 2011-04-19 | 高親和性低分子C5a受容体調節物質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004525873A JP2004525873A (ja) | 2004-08-26 |
| JP2004525873A5 true JP2004525873A5 (https=) | 2007-11-22 |
| JP5260818B2 JP5260818B2 (ja) | 2013-08-14 |
Family
ID=21741822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002551496A Expired - Fee Related JP5260818B2 (ja) | 2000-09-29 | 2000-09-29 | 高親和性低分子C5a受容体調節物質 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1322309B1 (https=) |
| JP (1) | JP5260818B2 (https=) |
| KR (1) | KR20030060887A (https=) |
| CN (1) | CN1454086A (https=) |
| AT (1) | ATE404553T1 (https=) |
| AU (1) | AU7622500A (https=) |
| BR (1) | BR0017338A (https=) |
| DE (1) | DE60039921D1 (https=) |
| IL (1) | IL154993A0 (https=) |
| MX (1) | MXPA03002788A (https=) |
| NO (1) | NO20031370L (https=) |
| WO (1) | WO2002049993A2 (https=) |
| YU (1) | YU23503A (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
| CA2479930A1 (en) * | 2002-03-28 | 2003-10-09 | Neurogen Corporation | Substituted tetrahydroisoquinolines as c5a receptor modulators |
| US6858637B2 (en) | 2002-03-28 | 2005-02-22 | Neurogen Corporation | Substituted biaryl amides as C5a receptor modulators |
| EP1487796A4 (en) * | 2002-03-28 | 2005-11-16 | Neurogen Corp | SUBSTITUTED BIARYLAMIDES AS MODULATORS OF THE C5A RECEPTOR |
| KR20040093487A (ko) * | 2002-03-29 | 2004-11-05 | 뉴로젠 코포레이션 | C5a 수용체 조절자로서의 신규 아릴이미다졸 및 관련화합물 |
| GB0214139D0 (en) * | 2002-06-19 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
| US7169775B2 (en) | 2002-08-21 | 2007-01-30 | Neurogen Corporation | Amino methyl imidazoles as C5a receptor modulators |
| AU2003261974A1 (en) | 2002-09-11 | 2004-04-30 | Kureha Chemical Industry Company, Limited | Amine compounds and use thereof |
| AU2003291403A1 (en) | 2002-11-08 | 2004-06-03 | Neurogen Corporation | 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| EP2266606B1 (en) | 2003-05-15 | 2014-09-10 | Genentech, Inc. | Methods and compositions for the prevention and treatment of sepsis |
| JP3977411B2 (ja) | 2004-03-10 | 2007-09-19 | 株式会社クレハ | アミン系塩基性化合物とその用途 |
| WO2006012373A2 (en) * | 2004-07-20 | 2006-02-02 | Critical Therapeutics, Inc. | Combination therapies of hmgb and complement inhibitors against inflammation |
| JP2007284352A (ja) * | 2004-08-05 | 2007-11-01 | Dai Ichi Seiyaku Co Ltd | ピラゾール誘導体 |
| WO2006060424A2 (en) | 2004-12-01 | 2006-06-08 | Kalypsys, Inc. | Inducible nitric oxide synthase dimerization inhibitors |
| JP2008530229A (ja) | 2005-02-17 | 2008-08-07 | ワイス | シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体 |
| EP1739078A1 (de) | 2005-05-30 | 2007-01-03 | Jerini AG | C5a-Rezeptor-Antagonisten |
| RS54998B1 (sr) | 2008-12-22 | 2016-11-30 | Chemocentryx Inc | Antagonisti c5ar |
| RS56332B1 (sr) | 2010-06-24 | 2017-12-29 | Chemocentryx Inc | Antagonisti c5ar |
| MX2015014688A (es) * | 2013-04-22 | 2016-02-19 | Abbvie Inc | Tiazoles y usos de los mismos. |
| DK3200791T3 (da) | 2014-09-29 | 2020-05-25 | Chemocentryx Inc | Fremgangsmåder og mellemprodukter i fremstilling af C5AR- antagonister |
| EP3072891A1 (en) * | 2015-03-24 | 2016-09-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | New Toll-Like Receptor 9 Antagonists |
| JP7339733B2 (ja) | 2016-01-14 | 2023-09-06 | ケモセントリックス,インコーポレイティド | C3腎症を処置する方法 |
| EP3439658B1 (en) | 2016-04-04 | 2021-11-24 | ChemoCentryx, Inc. | Soluble c5ar antagonists |
| WO2018222601A1 (en) | 2017-05-31 | 2018-12-06 | Chemocentryx, Inc. | 5-5 FUSED RINGS AS C5a INHIBITORS |
| US10562896B2 (en) | 2017-05-31 | 2020-02-18 | Chemocentryx, Inc. | 6-5 fused rings as C5a inhibitors |
| CA3077395A1 (en) | 2017-10-30 | 2019-05-09 | Chemocentryx, Inc. | Deuterated compounds as immunomodulators |
| WO2019126424A1 (en) | 2017-12-22 | 2019-06-27 | Chemocentryx, Inc. | DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS |
| MX2020006460A (es) | 2017-12-22 | 2020-11-06 | Chemocentryx Inc | Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar. |
| BR112020019822A2 (pt) | 2018-04-02 | 2021-03-16 | Chemocentryx, Inc. | Profármacos de antagonistas bicíclicos fundidos de c5ar |
| CN114957165A (zh) * | 2021-02-26 | 2022-08-30 | 清华大学 | 一种抗病毒化合物及其制备方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6157590A (ja) * | 1984-08-29 | 1986-03-24 | Asahi Shiyueebell Kk | シラン化合物およびその製造法 |
| US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
| US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| MX9308025A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. |
| US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
| EP0793653A1 (en) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| GB9426103D0 (en) * | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Therapeutic agents |
| AR007857A1 (es) * | 1996-07-13 | 1999-11-24 | Glaxo Group Ltd | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen. |
| JP2001517245A (ja) * | 1997-05-29 | 2001-10-02 | メルク エンド カンパニー インコーポレーテッド | 細胞接着阻害薬としてのビアリールアルカン酸類 |
| MY153569A (en) * | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
| CN1181817C (zh) * | 1998-03-20 | 2004-12-29 | 第一三得利制药株式会社 | 以苯基甲苯醌为有效成分的NF-kB抑制剂 |
| KR100605140B1 (ko) * | 1998-05-22 | 2006-07-28 | 싸이오스 인크 | 심장병 및 다른 질병을 치료하기 위한 헤테로 고리 화합물및 그 치료 방법 |
| US6365602B1 (en) * | 1998-07-10 | 2002-04-02 | Astra Zeneca Ab | N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| US6423519B1 (en) * | 1998-07-15 | 2002-07-23 | Gpc Biotech Inc. | Compositions and methods for inhibiting fungal growth |
| WO2000010573A1 (en) * | 1998-08-21 | 2000-03-02 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| WO2000025780A1 (en) * | 1998-10-29 | 2000-05-11 | Bristol-Myers Squibb Company | Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| US6503905B1 (en) * | 1998-12-29 | 2003-01-07 | Pfizer Inc | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| AP1654A (en) * | 1999-03-24 | 2006-09-01 | Anormed Inc | Chemokine receptor binding heterocyclic compounds. |
| US6369226B1 (en) * | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| AU7031500A (en) * | 1999-09-23 | 2001-04-24 | Astrazeneca Ab | Therapeutic quinazoline compounds |
| US6734191B2 (en) * | 2000-09-15 | 2004-05-11 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
-
2000
- 2000-09-29 JP JP2002551496A patent/JP5260818B2/ja not_active Expired - Fee Related
- 2000-09-29 CN CN00819935A patent/CN1454086A/zh active Pending
- 2000-09-29 BR BR0017338-0A patent/BR0017338A/pt not_active IP Right Cessation
- 2000-09-29 YU YU23503A patent/YU23503A/sh unknown
- 2000-09-29 AU AU7622500A patent/AU7622500A/xx active Pending
- 2000-09-29 DE DE60039921T patent/DE60039921D1/de not_active Expired - Lifetime
- 2000-09-29 AT AT00965522T patent/ATE404553T1/de not_active IP Right Cessation
- 2000-09-29 EP EP00965522A patent/EP1322309B1/en not_active Expired - Lifetime
- 2000-09-29 IL IL15499300A patent/IL154993A0/xx unknown
- 2000-09-29 WO PCT/US2000/026816 patent/WO2002049993A2/en not_active Ceased
- 2000-09-29 MX MXPA03002788A patent/MXPA03002788A/es unknown
- 2000-09-29 KR KR10-2003-7003410A patent/KR20030060887A/ko not_active Ceased
-
2003
- 2003-03-26 NO NO20031370A patent/NO20031370L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004525873A5 (https=) | ||
| US10653674B2 (en) | Multisubstituted aromatic compounds as inhibitors of thrombin | |
| EP1322309B1 (en) | High affinity small molecule c5a receptor modulators | |
| KR101214665B1 (ko) | 트리아졸 유도체 또는 그의 염 | |
| KR101589332B1 (ko) | 2h-크로멘 화합물 및 그의 유도체 | |
| JP2002511463A (ja) | インテグリンのそれの受容体への結合を阻害するn,n−ジ置換アミド | |
| TW415940B (en) | Condensed cyclic carboxylic acid compound or salt thereof, and medical composition containing which | |
| JPWO2000039116A1 (ja) | アミノピラゾール誘導体 | |
| HUP0104364A2 (hu) | Pirrolidinszármazékok, CCR-3 receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények | |
| WO2008023720A1 (en) | Urea compound or salt thereof | |
| JPH09501404A (ja) | 新規化合物 | |
| JP2007507529A (ja) | 複素環式アミドおよびスルホンアミド | |
| KR20060095865A (ko) | 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체 | |
| CN103228643B (zh) | 作为组胺h4受体配体的苯并唑衍生物 | |
| EP2379533A1 (en) | N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity | |
| CA2569654A1 (en) | Benzimidazolone carboxylic acid derivatives | |
| RU2453540C2 (ru) | 2,3-замещенные пиразинсульфонамиды в качестве ингибиторов crth2 | |
| JP2007518816A (ja) | バニロイド受容体リガンド及び炎症性及び神経因性疼痛の治療におけるこれらの使用 | |
| US20040010147A1 (en) | Cyclic amine compounds and pharmaceutical composition containing the same | |
| AU2003228419A1 (en) | New aryl imidazoles and related compounds as c5a receptor modulators | |
| WO2006106812A1 (ja) | プロパン-1,3-ジオン誘導体又はその塩 | |
| JP2007186422A (ja) | アリールスルフィド誘導体 | |
| RU2003105218A (ru) | Малые молекулы модуляторов рецепторов с5а высокой аффинности | |
| JP2015506967A (ja) | イミダゾリルケトン誘導体asdアルドステロン合成酵素阻害剤 | |
| JP2011219476A (ja) | 高親和性低分子C5a受容体調節物質 |